Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hetzer Medical Indonesia Tbk. (MEDS) vs Reksa Dana Premier ETF Indonesia Consumer (XIIC) Price & Performance

Hetzer Medical Indonesia Tbk.Trade
Reksa Dana Premier ETF Indonesia ConsumerTrade

Price performance (Past 24H)

Key statistics

Hetzer Medical Indonesia Tbk. vs Reksa Dana Premier ETF Indonesia Consumer — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp86 (market cap 139.06B, 51.66M 24h volume), while Reksa Dana Premier ETF Indonesia Consumer trades at Rp752 (market cap 1.62B, 12.7K 24h volume). The key difference: Hetzer Medical Indonesia Tbk. is far larger — about 85.8× Reksa Dana Premier ETF Indonesia Consumer's market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (51.66M versus 12.7K). Which is the better fit depends on your goals.

MEDSXIIC
Market Cap
139.06B1.62B
Volume
51.66M12.7K
Lot
516.62K127
Turnover
4.44B
Average Price
85.97
Value
4.44B
Indicative Equilibrium Price
86
Indicative Equilibrium Volume
9.62K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MEDS
View details

About Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Read more on MEDS

About Reksa Dana Premier ETF Indonesia Consumer

Read more on XIIC